Your shopping cart is currently empty

Human Factor XIIa Beta is an active fragment of coagulation factor XII, playing a crucial role in the intrinsic coagulation pathway and leading to clot formation. Additionally, Human Factor XIIa Beta is involved in the kallikrein-kinin system, resulting in the release of bradykinin (a vasodilator). Bradykinin stimulates the release of catecholamines and mediates its cardiovascular effects through a non-cholinergic, angiotensin-converting enzyme (ACE) regulatory mechanism.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Human Factor XIIa Beta is an active fragment of coagulation factor XII, playing a crucial role in the intrinsic coagulation pathway and leading to clot formation. Additionally, Human Factor XIIa Beta is involved in the kallikrein-kinin system, resulting in the release of bradykinin (a vasodilator). Bradykinin stimulates the release of catecholamines and mediates its cardiovascular effects through a non-cholinergic, angiotensin-converting enzyme (ACE) regulatory mechanism. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.